Induction of DMBT1 expression by reduced ERK activity during a gastric mucosa differentiation-like process and its association with human gastric cancer
Open Access
- 10 March 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 26 (6) , 1129-1137
Abstract
Abnormalities in the expression of DMBT1 (deleted in malignant brain tumors 1) have been implicated in the development of esophageal, gastric and colorectal cancers of the alimentary tract, but the underlying mechanism remains unclear. In the present study, using the gastric cell line AGS, we identified two intracellular signaling molecules protein kinase C (PKC) and extracellular signal-related kinase (ERK). They mediated both the phorbol myristate acetate (PMA) downregulation of DMBT1 expression and the initiation of cell differentiation, which was measured by cell cycle withdrawal and the induction of the tissue-specific marker trefoil factor 1 (TFF1). A time-course study showed that following the PMA activation of ERK kinase, the induction of TFF1 and the reduction of DMBT1 were detected at the same time point. We then demonstrated a minimal level of DMBT1 in proliferating AGS cells seeded at low density, where ERK activity was high. Reduction of ERK activity, either by an ERK inhibitor PD98059 or by high-density seeding, significantly reduced AGS cell growth judged by CFSE labeling. This cellular effect was elicited by cyclin D/p21 (Cip/Waf1) and G 0 /G 1 arrest, and was accompanied by a marked increase in DMBT1-expressing cells. Finally, we showed that siRNA directed against DMBT1 had no effect on the induction of a cell growth arrest marker, gut-enriched Kruppel-like factor (GKLF), but reduced the PMA induction of TFF1. Along with its upregulation coinciding with G 0 /G 1 arrest, and its attenuation in differentiated cells, these results suggest that the transient induction of DMBT1 is apparently specific at an early stage of gastric epithelial differentiation-like process, when it may play a role in cell fate decision. Consistent with such a potential function, we detected frequent abnormalities of the DMBT1 expression in the specimens of human gastric adenocarcinoma.Keywords
This publication has 37 references indexed in Scilit:
- The scavenger receptor, cysteine-rich domain-containing molecule gp-340 is differentially regulated in epithelial cell lines by phorbol esterClinical and Experimental Immunology, 2002
- Human salivary agglutinin binds to lung surfactant protein-D and is identical with scavenger receptor protein gp-340Biochemical Journal, 2001
- Analysis of the DMBT1 gene in carcinomas of the respiratory tractInternational Journal of Cancer, 2000
- Localization of Lung Surfactant Protein D on Mucosal Surfaces in Human TissuesThe Journal of Immunology, 2000
- Phenotypic Plasticity and Terminal Differentiation of the Intercalated Cell: The Hensin PathwayNephron Experimental Nephrology, 2000
- Cloning of gp-340, a putative opsonin receptor for lung surfactant protein DProceedings of the National Academy of Sciences, 1999
- Expression of the DMBT1 Gene Is Frequently Suppressed in Human Lung CancerJapanese Journal of Cancer Research, 1999
- Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progressionOncogene, 1998
- DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumoursNature Genetics, 1997
- CRP-ductin: A gene expressed in intestinal crypts and in pancreatic and hepatic ductsThe Anatomical Record, 1996